Home
Careers
Media
Contact us
Corporate Profile
Vision & Mission
History
Board of Directors
Certifications
Group Companies
Active Pharmaceutical Ingredients
Bulk Pharma Chemicals
Phosgene
Intermediates
Formulations
International
Domestic
Branded Formulations
Generic
Herbal Nutraceuticals
Veterinary
Contract / Collaborated Research Services
Alembic Research Center
Quality
Regulatory Affairs
Objectives
Activities
Macrolide Chemistry
Corporate Citizenship
Environment
Community
Corporate Overview
Letter from the Chairman
Stock Quote
Code of Conduct
Shareholding Pattern
Financial Results
Annual Report
Quarterly Reports
Events & Presentation
Investor Corner
Investor Presentation
Bifurcation of cost of Acquisition
Financial Results - Quarterly Report
Title
PDF
Unaudited Financial Results for the Quarter Ended on 31st Dec 2011
25.1 KB
Unaudited Financial Results for the quarter Ended on 30th Sept 2011
825.9 KB
Unaudited Financial Results for the quarter Ended on 30th June 2011
28.6 KB
Audited financial results for 31st March 2011
528.3 KB
Unaudited financial results for the Quarter ended 31st Dec 2010
22.4 KB
Investors
Corporate Overview
Letter from the Chairman
Stock Quote
Code of Conduct
Shareholding Pattern
Financial Results
Annual Report
Quarterly Reports
Events & Presentation
Investor Corner
Investor Presentation
Bifurcation of cost of Acquisition
